{"title":"Use of Dual-Energy X-ray Absorptiometry for Body Composition in Chronic Disease Management","authors":"Tae Nyun Kim","doi":"10.4093/jkd.2022.23.2.97","DOIUrl":"https://doi.org/10.4093/jkd.2022.23.2.97","url":null,"abstract":"Aging and chronic disease are often accompanied by changes in body composition that lead to decreased muscle mass and increased fat mass, even in weight-stable individuals. Both obesity and sarcopenia are important causes of frailty, disability, morbidity, and mortality. Diminished skeletal muscle and expanded visceral fat can act synergistically, which might maximize their effects on physical impairments and metabolic disorders. Dual-energy X-ray absorptiometry (DEXA) was regarded as one of the most versatile imaging techniques for evaluation of sarcopenia and obesity as well as osteoporosis. Whole-body DEXA allows total and regional assessment of the three compartments for fat mass, non-bone lean mass, and bone mineral content. Moreover, DEXA is accurate, reproducible, fast, relatively inexpensive, and involves very low radiation dose to the patient. Developments in DEXA equipment and software allow an accurate and differential estimate of visceral adipose tissue. This review summarizes the clinical practical application of whole-body DEXA values, with use of muscle and fat mass indices in the diagnostic workup of low muscle mass, sarcopenia, and sarcopenic obesity according to the most recent studies and guidelines.","PeriodicalId":366252,"journal":{"name":"The Journal of Korean Diabetes","volume":"70 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"123442653","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Aceruloplasminemia Presents as Type 2 Diabetes Associated with Unexplained Microcytic Anemia: A Case Report","authors":"B. Pak, E. Yoo, H. Park, Ji Hye Kim","doi":"10.4093/jkd.2022.23.2.144","DOIUrl":"https://doi.org/10.4093/jkd.2022.23.2.144","url":null,"abstract":"Aceruloplasminemia (ACP) is a rare genetic disorder characterized by the triad of diabetes mellitus, retinal degeneration, and neurological symptoms. The patient’s clinical and biochemical features highlight substantial phenotype heterogeneity, contributing to the difficulties and delay in diagnosing ACP. We described a patient presenting with diabetes and abnormal iron studies due to ACP with typical neuroradiologic abnormality. A 56-year-old female patient visited our hospital with complaints of weight loss and anxiety. The leading cause of unintentional weight loss was uncontrolled diabetes. She was treated with oral hypoglycemic agents. Initial blood tests revealed unexplained microcytic anemia and high ferritin levels. We performed magnetic resonance imaging (MRI) of the brain to alleviate her excessive concerns about normal memory loss. We suspected that she might have ACP, based on the results of cortical pencil lining sign of the brain MRI and microcytic anemia with decreased ceruloplasmin (CP) and increased ferritin levels. Sequence analysis of the CP gene revealed homozygosity for c.2630 G>A, confirming the clinical diagnosis of ACP. The patient was started on deferasirox with progressive normalization of ferritin. In conclusion, unexplained anemia, often with microcytosis, diabetes, and typical neuroradiologic findings, is the best clue for early diagnosis of ACP.","PeriodicalId":366252,"journal":{"name":"The Journal of Korean Diabetes","volume":"68 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"131639107","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Recent Advances in Anti-Obesity Drugs","authors":"J. Son","doi":"10.4093/jkd.2022.23.2.113","DOIUrl":"https://doi.org/10.4093/jkd.2022.23.2.113","url":null,"abstract":"Obesity is a chronic, complex, and heterogeneous disease that is affected by genetic, developmental, biological, and environmental factors; thus, it is necessary to approach obesity with an integrated and comprehensive treatment strategy. Because it is difficult to achieve and maintain successful long-term weight loss through lifestyle modifications in most obese patients, a pharmacological approach to the treatment of obesity should be considered as adjuvant therapy. According to the Korean Society for the Study of Obesity guidelines, patients who fail to lose weight with comprehensive lifestyle modifications and who have a body mass index of ≥ 25 kg/m2 are eligible for weight loss medication treatment. Four drugs (orlistat, naltrexone extended-release [ER]/bupropion ER, phentermine/topiramate controlled-release, and liraglutide) have been approved for long-term use (> 12 weeks) to promote weight loss in Korea. Here, I will discuss these currently available anti-obesity agents as well as upcoming anti-obesity agents including semaglutide, setmelanotide, and tirzepatide in terms of obesity management.","PeriodicalId":366252,"journal":{"name":"The Journal of Korean Diabetes","volume":"104 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"123621936","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Utility of Bioelectrical Impedance Analysis for Body Composition Assessment","authors":"Soo Lim","doi":"10.4093/jkd.2022.23.2.106","DOIUrl":"https://doi.org/10.4093/jkd.2022.23.2.106","url":null,"abstract":"People with obesity are at high risk of type 2 diabetes, cardiovascular diseases, and certain types of malignancy. A significant reduction in muscle mass is also associated with increased risk of developing sarcopenia. In general, body composition is affected by several factors, including ethnicity, environment, genetics, and lifestyle patterns. Assessment of body composition is an important tool for maintaining good general health and longevity, and is utilized by physicians and researchers to monitor disease severity and nutritional status. It can also be used to monitor the effectiveness of dietary and drug interventions. Dual energy X-ray absorptiometry is regarded as the gold standard method for analyzing body composition. However, there is an associated risk of a small amount of radiation exposure. In addition, severely obese people are not candidates for this method. Recently, bioelectrical impedance analysis (BIA) has been developed. BIA poses no radiation hazard, is easy applicable and relatively inexpensive. Thus, BIA is widely used in fitness centers as well as in hospitals. Several studies have been conducted to assess the effectiveness of BIA for measuring body composition, but most have focused on subjects of European descent. Of note, body composition differs among ethnic groups: Asians have a greater tendency toward obesity at a lower body mass index than Caucasians. Therefore, an ethnicity-specific approach is required for precise estimation of body composition using BIA. In conclusion, healthcare providers should have a thorough understanding of body composition assessment and the advantages and disadvantages of different measurement methods.","PeriodicalId":366252,"journal":{"name":"The Journal of Korean Diabetes","volume":"23 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"128641068","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Medical Nutrition Therapy Using Carbohydrate Counting","authors":"Mi Ra Kim","doi":"10.4093/jkd.2022.23.2.133","DOIUrl":"https://doi.org/10.4093/jkd.2022.23.2.133","url":null,"abstract":"Improved postprandial glucose management requires careful monitoring of carbohydrate counting and consideration of the blood glucose response to dietary carbohydrate. Furthermore, learning how to use insulin-to-carbohydrate ratios for meal planning might help people successfully adjust insulin dose from meal to meal to enhance glycemic control. Regular education to raise knowledge of the link between carbohydrate intake and insulin requirements is critical for those whose meal schedules or carbohydrate consumption are unpredictable. Medical nutrition therapy is an important part of total diabetes management, and each person with diabetes should participate actively in education, self-management, and treatment planning with their health care team, including creation of a personalized food plan.","PeriodicalId":366252,"journal":{"name":"The Journal of Korean Diabetes","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"129702529","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Pharmacological Treatment of Nonalcoholic Fatty Liver Disease: Antidiabetic Agents","authors":"Kyung-Soo Kim","doi":"10.4093/jkd.2022.23.2.83","DOIUrl":"https://doi.org/10.4093/jkd.2022.23.2.83","url":null,"abstract":"Nonalcoholic fatty liver disease (NAFLD) is the most common liver disorders and is associated with various metabolic diseases, including type 2 diabetes mellitus (T2DM). There are no approved drugs for NAFLD, and the only approved treatment option is weight reduction. However, it is not easy to maintain weight loss by lifestyle modification alone; pharmacological treatments are helpful in this regard. As insulin resistance plays an important role in the development of NAFLD, many antidiabetic drugs have been evaluated for treatment of NAFLD. Pioglitazone could be a first-line option to improve nonalcoholic steatohepatitis (NASH) in patients with T2DM to produce some improvement in fibrosis. Glucagon-like peptide-1 receptor agonists show evidence of improving NAFLD/NASH with fibrosis. Metformin and dipeptidyl peptidase-4 inhibitors are not recommended for treating NAFLD in patients with T2DM. Evidence that sodium-glucose cotransporter 2 inhibitors improve NAFLD/NASH with fibrosis in patients with T2DM is emerging.","PeriodicalId":366252,"journal":{"name":"The Journal of Korean Diabetes","volume":"29 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"116494784","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Individualized Medical Nutrition Therapy for Diabetic Patients according to Diabetes Medication","authors":"Juyeon Park","doi":"10.4093/jkd.2022.23.1.50","DOIUrl":"https://doi.org/10.4093/jkd.2022.23.1.50","url":null,"abstract":"Medical nutrition therapy (MNT) plays an important role in diabetes management. For effective MNT, not only an individualized meal plan considering daily eating habits and preferences, but also overall management strategies and adjustments on drug therapy and physical activity are required. In particular, an individualized meal plan is needed based on an understanding of the medicine’s mechanism and side effects, because glucose is controlled well only when prescription medicines and diet are in harmony.","PeriodicalId":366252,"journal":{"name":"The Journal of Korean Diabetes","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-03-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"115711654","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Blood Pressure Variability and Diabetes Mellitus","authors":"C. Jeong, T. Sohn","doi":"10.4093/jkd.2022.23.1.21","DOIUrl":"https://doi.org/10.4093/jkd.2022.23.1.21","url":null,"abstract":"Increased blood pressure variability (BPV) has been found to significantly increase the risk of cardiovascular morbidity and mortality in the non-diabetic population. The prognostic importance of increased BPV for the development of micro- and macrovascular complications in type 2 diabetes has been investigated. Type 2 diabetes can increase BPV through different mechanisms, including increased arterial stiffness and autonomic dysfunction. Several studies in type 2 diabetic patients showed inconclusive results regarding all-cause mortality, microvascular complication, and extended major adverse cardiovascular events (MACE). However, some trials showed that BPV might be regarded as a potentially important therapeutic target in the management of type 2 diabetes regarding MACE. For now, the primary goal of antihypertensive treatment in patients with type 2 diabetes shall remain to controll mean blood pressure levels. However, when future studies show consistent results, BPV might be regarded as a therapeutic target in type 2 diabetic patients.","PeriodicalId":366252,"journal":{"name":"The Journal of Korean Diabetes","volume":"20 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-03-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"122188473","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Microbiome and Diabetes","authors":"Jin Hwa Kim","doi":"10.4093/jkd.2022.23.1.7","DOIUrl":"https://doi.org/10.4093/jkd.2022.23.1.7","url":null,"abstract":"The prevalence of metabolic diseases such as obesity, type 2 diabetes, and insulin resistance continues to rise. These conditions are associated with multiple social, genetic, and environmental risk factors, including the human gut microbiota, which has emerged as a critical mediator linked to metabolic disease. Recent evidence suggests that the gut microbiota has personalized effects on the gut–brain axis, which controls metabolic function. Gut microbiota can be a great source of prognostic biomarkers and therapies for metabolic diseases. The microbiome also influences immune system development and homeostasis. In this review, I summarize recent findings regarding the association between the gut microbiome and type 2 diabetes. These findings will inform future diabetes mellitus prevention, diagnosis, and treatment strategies.","PeriodicalId":366252,"journal":{"name":"The Journal of Korean Diabetes","volume":"28 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-03-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"126174422","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Effect of Motivational Interviewing Training on Diabetes Educators’ Counseling Skills and Self-Efficacy","authors":"S. Lim","doi":"10.4093/jkd.2022.23.1.57","DOIUrl":"https://doi.org/10.4093/jkd.2022.23.1.57","url":null,"abstract":"The purpose of this study was to examine the effects of motivational interviewing (MI) training on diabetes educators’ counseling skills and self-efficacy. Diabetes educators were randomly allocated to the MI training group or control group. The experimental group was provided with a one-day course on MI. Pre-, post-, and follow-up (F/U) measurements were compared. Twenty-four diabetes educators participated in this study. Scores on the counseling skills post-test and F/U-test increased significantly compared to pre-test in the MI training group, as did scores on the helping skill self-efficacy post-test and F/U-test. Session management self-efficacy post-test scores also increased significantly compared to pre-test in the MI training group. There were no significant differences in pre-post and pre-F/U scores in the control group. Diabetes educator-patient communication is an important factor affecting the management of diabetes. MI training increases the counseling skills & self-efficacy of diabetes educators. Diabetes educators should use MI to facilitate patient health behavior changes in diabetes education.","PeriodicalId":366252,"journal":{"name":"The Journal of Korean Diabetes","volume":"101 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-03-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"132561915","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}